M&A Deal Summary

RISE Life Science Acquires PreMD

On August 5, 2010, RISE Life Science acquired medical products company PreMD

Acquisition Highlights
  • This is RISE Life Science’s 1st transaction in the Medical Products sector.
  • This is RISE Life Science’s 1st transaction in Canada.
  • This is RISE Life Science’s 1st transaction in Ontario.

M&A Deal Summary

Date 2010-08-05
Target PreMD
Sector Medical Products
Buyer(s) RISE Life Science
Deal Type Add-on Acquisition

Target

PreMD

Toronto, Ontario, Canada
PreMD is a provider of predictive medicine, dedicated to developing rapid, non-invasive tests for the early detection of life-threatening diseases. PreMD's cardiovascular products are branded as PREVU Skin Sterol Test. The company's cancer tests include ColorectAlert(TM), LungAlert(TM) and a breast cancer test. PreMD was founded in 1992 and is based in Toronto, Ontario.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

RISE Life Science

Toronto, Ontario, Canada

Category Company
Sector Life Science
DESCRIPTION

RISE Life Science is a developer of cannabis-based consumer products for both medical and adult-use markets around the world. All products are based on patent-pending formulations and processes to produce specific targeted effects.


DEAL STATS #
Overall 1 of 1
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Ontario M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2010 M&A 1 of 1